Product Information
NYSTATIN 100,000 UNIT/GM POWD is a generic product labeled by Leading Pharma, LLC, priced at $0.3134 per GM under NDC 69315030630. Its NADAC has been published 437 times since May 23, 2018.
FDA first approved this application on May 30, 2017. Its Orange Book therapeutic-equivalence code is AT.
Strength
100000 [USP'U]/g
Manufacturer
Leading Pharma, LLCNDC
69315030630
Classification
Generic
Dosage Form
POWDER
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
NYSTATINApproval Type
Generic (ANDA)
FDA Application
ANDA208838FDA Approved
5/30/2017
TE Code
AT
On Market Since
4/23/2018
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN 100,000 UNIT/GM POWD has been published 437 times since May 23, 2018, and over the history we have for it it has declined 24.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3134 per GM |
|---|---|
| All-time high | $0.4482 (Apr 10, 2024) |
| All-time low | $0.2457 (May 17, 2023) |
| 52-week high | $0.3499 |
| 52-week low | $0.3064 |
| Median price | $0.3126 |
| Average price | $0.3169 |
| Largest weekly change | -32.7% (Nov 20, 2024) |
| Weeks tracked | 437 |
| Tracking since | May 23, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Leading Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
NYSTATIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Polyene Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NYSTATIN 100,000 UNIT/GM POWD?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN 100,000 UNIT/GM POWD, manufactured by Leading Pharma, LLC, is $0.3134 per GM (NDC 69315030630), effective Sep 30, 2026.
How has the price of NYSTATIN 100,000 UNIT/GM POWD changed over time?
Over the history we have for it, the NADAC for NYSTATIN 100,000 UNIT/GM POWD has declined 24.4%. It has been tracked across 437 weekly CMS publications since May 23, 2018.
What are the highest and lowest recorded NADAC prices for NYSTATIN 100,000 UNIT/GM POWD?
Since May 23, 2018, the NADAC for NYSTATIN 100,000 UNIT/GM POWD has ranged from a low of $0.2457 (May 17, 2023) to a high of $0.4482 (Apr 10, 2024), with a median of $0.3126 per GM.
Are there cheaper alternatives to NYSTATIN 100,000 UNIT/GM POWD?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN 100,000 UNIT/GM POWD, is $0.2574 per GM — about 18% below NYSTATIN 100,000 UNIT/GM POWD.
Who manufactures NYSTATIN 100,000 UNIT/GM POWD?
NYSTATIN 100,000 UNIT/GM POWD (NDC 69315030630) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.